Do I need a Testosterone / Estradiol (T:E2) test?
Are you noticing irregular periods, unexpected hair growth, or fertility challenges? Your testosterone and estradiol levels might give you important clues about what's going on.
The testosterone-to-estradiol ratio measures the balance between your androgens and oestrogens — two hormone families that work together to regulate your cycle, metabolism, and overall wellbeing.
Understanding this ratio can help you and your health practitioner identify hormonal imbalances and make informed decisions about your health. When your hormones are out of balance, it may affect everything from your menstrual regularity to your energy levels. This biomarker is included in Listen Health's comprehensive female health panel, so you can get a clear picture of your hormonal landscape.
What is it?
The testosterone-to-estradiol (T:E2) ratio measures the balance between androgens (male-type hormones like testosterone) and oestrogens (female-type hormones like estradiol) in women. This ratio is a key marker for understanding hormonal equilibrium, particularly in evaluating polycystic ovary syndrome (PCOS) and other endocrine or metabolic disorders.
Testosterone and estradiol are interconnected — testosterone is converted to estradiol by an enzyme called aromatase. When this conversion is disrupted, it can lead to either androgen excess or oestrogen deficiency, both of which affect menstrual regularity, fertility, and metabolic health.
Book Your Test Now
Test Testosterone / Estradiol (T:E2) as part of 100+ biomarkers with Listen Health's annual membership.
Start Testing TodayWhy does it matter?
An imbalanced T:E2 ratio is a hallmark of PCOS, a condition characterised by hyperandrogenism (high testosterone) and ovulatory dysfunction.
A low estradiol-to-testosterone (E2:T) ratio — or high T:E2 ratio — reflects reduced aromatase activity and elevated androgen levels, leading to symptoms such as acne, excess hair growth (hirsutism), and irregular cycles.
Women with a low E2:T ratio often show higher cardiovascular risk, insulin resistance, and impaired lipid metabolism. These metabolic disruptions may increase long-term risks for type 2 diabetes and heart disease.
Because the ratio links sex hormone metabolism with metabolic health, it’s also a powerful early indicator of how well the body is balancing hormonal and metabolic demands.
What causes fluctuations?
Several physiological and lifestyle factors can alter the T:E2 ratio:
PCOS and Insulin Resistance: High insulin levels suppress SHBG production and increase free testosterone, amplifying androgen excess.
Obesity and Metabolic Dysfunction: Higher body fat impairs aromatase activity, reducing the conversion of testosterone to estradiol.
Thyroid and Liver Health: Both influence SHBG production and hormone metabolism, indirectly shifting the T:E2 balance.
Stress and Chronic Inflammation: Cortisol dysregulation and inflammatory cytokines interfere with hormone synthesis and receptor sensitivity.
Recommendations
If your T:E2 ratio is imbalanced, focusing on the root cause is key:
Stabilize Blood Sugar: A diet low in refined carbs and rich in fiber, protein, and healthy fats improves insulin sensitivity and reduces androgen excess.
Exercise Regularly: Strength and aerobic training enhance aromatase activity and restore hormone balance.
Support Liver Function: Cruciferous vegetables (broccoli, kale, cabbage) and adequate hydration aid estrogen metabolism.
Manage Stress: Mindfulness and restorative sleep help normalize cortisol and reproductive hormones.
Medical Support: Clinicians may assess for PCOS, insulin resistance, thyroid function, or hormonal therapies depending on the imbalance.
References
Amato, M. C., Verghi, M., Nucera, M., Galluzzo, A., & Giordano, C. (2011). Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome. Gynecological Endocrinology, 27(8), 579–586. https://doi.org/10.3109/09513590.2010.495797
Ge, J., Yang, N., Zhang, X., et al. (2022). Steroid hormone profiling in hyperandrogenism and non-hyperandrogenism women with polycystic ovary syndrome. Reproductive Sciences, 29(12), 3449–3458. https://doi.org/10.1007/s43032-022-00985-0
Franik, G., Maksym, M., Owczarek, A. J., et al. (2019). Estradiol/testosterone and estradiol/androstenedione indexes and nutritional status in PCOS women—a pilot study. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 242, 166–169. https://doi.org/10.1016/j.ejogrb.2019.05.045
Dewailly, D., Robin, G., Peigne, M., et al. (2016). Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.Human Reproduction Update, 22(6), 709–724. https://doi.org/10.1093/humupd/dmw027
Frequently Asked Questions
Related Biomarkers
Prolactin
Testosterone, Total
Free Androgen Index (FAI)
Thyroid-Stimulating Hormone
Triiodothyronine (T3) Free
Iron
AHPRA Disclaimer: This information is general in nature and should not replace individual medical advice. Always discuss your test results and health concerns with a registered healthcare practitioner.